Jared Gollob
Chief Tech/Sci/R&D Officer presso KYMERA THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Jared Gollob is currently the Chief Medical Officer at Kymera Therapeutics, Inc. Prior to this, he was the Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Before that, he was the Director-Biologic Therapy Program at Duke University from 2002 to 2007.
Dr. Gollob received his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 04/03/2024 | 95 740 ( 0.16% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Jared Gollob
| Società | Posizione | Inizio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
Precedenti posizioni note di Jared Gollob
| Società | Posizione | Fine |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/09/2007 |
Formazione di Jared Gollob
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Jared Gollob
